| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| FHJ33910A |
Anti-Human CD100/SEMA4D Antibody (VX15/2503) |
50 µg |
$285.00
|
 |
BUY
|
| FHJ33910B |
Anti-Human CD100/SEMA4D Antibody (VX15/2503) |
100 µg |
$430.00
|
|
BUY
|
| FHE57010A |
Anti-Human CD295/LEPR Antibody (SAA0096) |
50 µg |
$285.00
|
|
BUY
|
| FHE57010B |
Anti-Human CD295/LEPR Antibody (SAA0096) |
100 µg |
$430.00
|
|
BUY
|
| FHD72110B |
Anti-Human CD314/KLRK1 Antibody (SAA0098) |
100 µg |
$310.00
|
|
BUY
|
| FHD72110A |
Anti-Human CD314/KLRK1 Antibody (SAA0098) |
50 µg |
$210.00
|
|
BUY
|
| RHG84901A |
Anti-Human IL11RA (SAA2023) mAb |
100µg |
$390.00
|
|
BUY
|
| RHG84901B |
Anti-Human IL11RA (SAA2023) mAb |
1mg |
$1,710.00
|
|
BUY
|
| DHJ14403A |
Research Grade Anti-Human CD272/BTLA (ANB032) |
100 µg |
$475.00
|
|
BUY
|
| DHJ14403B |
Research Grade Anti-Human CD272/BTLA (ANB032) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHD50703A |
Research Grade Anti-Human IL10 (MK-1966) mAb |
|
$475.00
|
|
BUY
|
| DHD50703B |
Research Grade Anti-Human IL10 (MK-1966) mAb |
|
$1,705.00
|
|
BUY
|
| DHG84901B |
Research Grade Anti-Human IL11RA (X209) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHG84901A |
Research Grade Anti-Human IL11RA (X209) mAb |
100 µg |
$475.00
|
|
BUY
|
| DHC33701A |
Research Grade Atibuclimab |
100 ug |
$380.00
|
|
BUY
|
| DHC33701B |
Research Grade Atibuclimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC25203A |
Research Grade Axatilimab |
100 ug |
$380.00
|
|
BUY
|
| DHC25203B |
Research Grade Axatilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02203A |
Research Grade Balstilimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02203B |
Research Grade Balstilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE85001A |
Research Grade Bertilimumab |
100 ug |
$420.00
|
|
BUY
|
| DHE85001B |
Research Grade Bertilimumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD68902A |
Research Grade Bleselumab |
100 ug |
$380.00
|
|
BUY
|
| DHD68902B |
Research Grade Bleselumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC25201A |
Research Grade Cabiralizumab |
100 ug |
$380.00
|
|
BUY
|
| DHC25201B |
Research Grade Cabiralizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02211A |
Research Grade Camrelizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02211B |
Research Grade Camrelizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB95904B |
Research Grade Cedelizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB95904A |
Research Grade Cedelizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02204A |
Research Grade Cetrelimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02204B |
Research Grade Cetrelimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD30404B |
Research Grade Encelimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD30404A |
Research Grade Encelimab |
100 ug |
$420.00
|
|
BUY
|
| DHH02220B |
Research Grade Ezabenlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02220A |
Research Grade Ezabenlimab |
100 ug |
$380.00
|
|
BUY
|
| DHB91702A |
Research Grade Fasinumab |
100 ug |
$380.00
|
|
BUY
|
| DHB91702B |
Research Grade Fasinumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92102B |
Research Grade Feladilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ92102A |
Research Grade Feladilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD30405B |
Research Grade Fianlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD30405A |
Research Grade Fianlimab |
100 ug |
$380.00
|
|
BUY
|
| DHJ69101A |
Research Grade Fletikumab |
100 ug |
$380.00
|
|
BUY
|
| DHJ69101B |
Research Grade Fletikumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB91601A |
Research Grade Fresolimumab |
100 ug |
$380.00
|
|
BUY
|
| DHB91601B |
Research Grade Fresolimumab |
1.0 mg |
$1,378.00
|
|
BUY
|
| DHD30401A |
Research Grade Ieramilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD30401B |
Research Grade Ieramilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD15102B |
Research Grade Inclacumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHD15102A |
Research Grade Inclacumab |
100 ug |
$380.00
|
|
BUY
|
| DHB74002B |
Research Grade Itepekimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB74002A |
Research Grade Itepekimab |
100 ug |
$380.00
|
|
BUY
|
| DHE07702B |
Research Grade Lebrikizumab |
1.0 mg |
$1,720.00
|
|
BUY
|
| DHE07702A |
Research Grade Lebrikizumab |
100 ug |
$470.00
|
|
BUY
|
| DHE85401B |
Research Grade Leronlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHE85401A |
Research Grade Leronlimab |
100 ug |
$380.00
|
|
BUY
|
| DHE43401A |
Research Grade Lirilumab |
100 ug |
$380.00
|
|
BUY
|
| DHE43401B |
Research Grade Lirilumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHB91602A |
Research Grade Metelimumab |
100 ug |
$380.00
|
|
BUY
|
| DHB91602B |
Research Grade Metelimumab |
1.0 ug |
$1,380.00
|
|
BUY
|
| DHE57001A |
Research Grade Mibavademab |
100 ug |
$420.00
|
|
BUY
|
| DHE57001B |
Research Grade Mibavademab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ63105A |
Research Grade Mirikizumab |
100 ug |
$420.00
|
|
BUY
|
| DHJ63105B |
Research Grade Mirikizumab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD80805B |
Research Grade Modakafusp alfa |
1.0 mg |
$1,560.00
|
|
BUY
|
| DHD80805A |
Research Grade Modakafusp alfa |
100 ug |
$430.00
|
|
BUY
|
| DHD71901A |
Research Grade Monalizumab |
100 ug |
$380.00
|
|
BUY
|
| DHD71901B |
Research Grade Monalizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC90715B |
Research Grade Odronextamab |
1.0 mg |
$2,030.00
|
|
BUY
|
| DHC90715A |
Research Grade Odronextamab |
100 ug |
$560.00
|
|
BUY
|
| DHC15804B |
Research Grade Olokizumab |
1.0 mg |
$1,562.00
|
|
BUY
|
| DHC15804A |
Research Grade Olokizumab |
100 ug |
$428.00
|
|
BUY
|
| DHJ70105B |
Research Grade Pacmilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ70105A |
Research Grade Pacmilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD30403A |
Research Grade Relatlimab |
100 ug |
$380.00
|
|
BUY
|
| DHD30403B |
Research Grade Relatlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC42201B |
Research Grade Rinucumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHC42201A |
Research Grade Rinucumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02219B |
Research Grade Sasanlimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02219A |
Research Grade Sasanlimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02213A |
Research Grade Serplulimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02213B |
Research Grade Serplulimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02207B |
Research Grade Sintilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02207A |
Research Grade Sintilimab |
100 ug |
$380.00
|
|
BUY
|
| DHH02214A |
Research Grade Spartalizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02214B |
Research Grade Spartalizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ85302B |
Research Grade Tabalumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHJ85302A |
Research Grade Tabalumab |
100 ug |
$380.00
|
|
BUY
|
| DHH72406A |
Research Grade Tamgiblimab |
100 ug |
$420.00
|
|
BUY
|
| DHH72406B |
Research Grade Tamgiblimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHD72101A |
Research Grade Tesnatilimab |
100 ug |
$380.00
|
|
BUY
|
| DHD72101B |
Research Grade Tesnatilimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02206A |
Research Grade Tislelizumab |
100 ug |
$380.00
|
|
BUY
|
| DHH02206B |
Research Grade Tislelizumab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02208B |
Research Grade Toripalimab |
1.0 mg |
$1,380.00
|
|
BUY
|
| DHH02208A |
Research Grade Toripalimab |
100 ug |
$380.00
|
|
BUY
|
| DHJ27904A |
Research Grade Ucenprubart |
100 µg |
$475.00
|
|
BUY
|
| DHJ27904B |
Research Grade Ucenprubart |
1.0 mg |
$1,715.00
|
|
BUY
|
| DHF39901B |
Research Grade Ulocuplumab (BMS-936564 / MDX-1338) |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHF39901A |
Research Grade Ulocuplumab (BMS-936564 / MDX-1338) |
100 ug |
$420.00
|
|
BUY
|
